In court documents, the state prosecutors lay out a brazen price-fixing scheme involving more than a dozen generic drug companies, including Teva, Pfizer, Novartis and Mylan. A key element of the scheme was an agreement among competitors to cooperate on pricing so each company could maintain a “fair share” of the generic drug markets, the complaint alleges.
from Kaiser Health News http://bit.ly/2Jhwghd
May 13, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
What Takes So Long? A Behind-The-Scenes Look At The Steps Involved In COVID-19 TestingAfter a slow start, testing for COVID-19 has ramped up in recent weeks, with giant commercial labs jumping into the effort, drive-up testing sites established in some places and new types of tests approved under emergency rul… Read More
VA Says It Stands Ready To Offer Overflow Help For Hospitals Strained By Crisis But Trump Needs To Give Go-Ahead“At this time, VA has not received specific requests from FEMA for assistance," the agency said. Veterans Affairs hospitals are supposed to serve as backup in times of crisis, but VA Secretary Robert Wilkie has made clear the… Read More
Access To Abortion Shrinks Further As More States Halt The Procedure During PandemicIn Texas, abortion providers talk about the way the state's new restrictions on the procedure is already impacting patients. Meanwhile, Oklahoma's governor says its suspension of elective surgeries includes abortion, unless n… Read More
Coronavirus Patients Caught In Conflict Between Hospital And Nursing HomesA wrenching conflict is emerging as the COVID-19 virus storms through U.S. communities: Some patients are falling into a no man’s land between hospitals and nursing homes. Hospitals need to clear out patients who no longer ne… Read More
First Edition: March 30, 2020Today's early morning highlights from the major news organizations. from Kaiser Health News https://ift.tt/2RbGORx … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment